129 related articles for article (PubMed ID: 10465419)
1. Synthesis and biological activities of phenylahistin derivatives.
Kanoh K; Kohno S; Katada J; Takahashi J; Uno I; Hayashi Y
Bioorg Med Chem; 1999 Jul; 7(7):1451-7. PubMed ID: 10465419
[TBL] [Abstract][Full Text] [Related]
2. (-)-Phenylahistin arrests cells in mitosis by inhibiting tubulin polymerization.
Kanoh K; Kohno S; Katada J; Takahashi J; Uno I
J Antibiot (Tokyo); 1999 Feb; 52(2):134-41. PubMed ID: 10344567
[TBL] [Abstract][Full Text] [Related]
3. Total synthesis of anti-microtubule diketopiperazine derivatives: phenylahistin and aurantiamine.
Hayashi Y; Orikasa S; Tanaka K; Kanoh K; Kiso Y
J Org Chem; 2000 Dec; 65(24):8402-5. PubMed ID: 11101408
[No Abstract] [Full Text] [Related]
4. Design and Synthesis of Novel Phenylahistin Derivatives Based on Co-Crystal Structures as Potent Microtubule Inhibitors for Anti-Cancer Therapy.
Ding Z; Li F; Xie L; Gu M; Li C; Liu C; Peng C; Li W
Mar Drugs; 2022 Nov; 20(12):. PubMed ID: 36547899
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationship study of antimicrotubule agents phenylahistin derivatives with a didehydropiperazine-2,5-dione structure.
Yamazaki Y; Tanaka K; Nicholson B; Deyanat-Yazdi G; Potts B; Yoshida T; Oda A; Kitagawa T; Orikasa S; Kiso Y; Yasui H; Akamatsu M; Chinen T; Usui T; Shinozaki Y; Yakushiji F; Miller BR; Neuteboom S; Palladino M; Kanoh K; Lloyd GK; Hayashi Y
J Med Chem; 2012 Feb; 55(3):1056-71. PubMed ID: 22185476
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design and synthesis of novel furan-diketopiperazine-type derivatives as potent microtubule inhibitors for treating cancer.
Ding Z; Li F; Zhong C; Li F; Liu Y; Wang S; Zhao J; Li W
Bioorg Med Chem; 2020 May; 28(10):115435. PubMed ID: 32278711
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of New Arylidene 2,5-Diketopiperazines and Evaluation of their Anti-Acetylcholinesterase, Anti-xanthine Oxidase, Anti-diabetic and Cytotoxic Activities.
Belkacem MA; Jannet HB; Ferhout H; Mzali L; Bouajila J
Med Chem; 2017; 13(8):744-752. PubMed ID: 28480832
[TBL] [Abstract][Full Text] [Related]
8. Unique diketopiperazine dimers from the insect pathogenic fungus Verticillium hemipterigenum BCC 1449.
Isaka M; Palasarn S; Rachtawee P; Vimuttipong S; Kongsaeree P
Org Lett; 2005 May; 7(11):2257-60. PubMed ID: 15901183
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of phenylahistin in vitro and in vivo.
Kanoh K; Kohno S; Katada J; Hayashi Y; Muramatsu M; Uno I
Biosci Biotechnol Biochem; 1999 Jun; 63(6):1130-3. PubMed ID: 10427703
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of benzophenone-bearing diketopiperazine-type anti-microtubule agents.
Yamazaki Y; Sumikura M; Masuda Y; Hayashi Y; Yasui H; Kiso Y; Chinen T; Usui T; Yakushiji F; Potts B; Neuteboom S; Palladino M; Lloyd GK; Hayashi Y
Bioorg Med Chem; 2012 Jul; 20(14):4279-89. PubMed ID: 22727370
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of phenylahistin enantiomers by cytochromes P450: a possible explanation for their different cytotoxicity.
Perrin L; Aninat C; Hamon V; Hayashi Y; Abadie C; Heyd B; André F; Delaforge M
Drug Metab Dispos; 2008 Nov; 36(11):2381-92. PubMed ID: 18687804
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of tryprostatin B and demethoxyfumitremorgin C analogues.
Wang H; Usui T; Osada H; Ganesan A
J Med Chem; 2000 Apr; 43(8):1577-85. PubMed ID: 10780915
[TBL] [Abstract][Full Text] [Related]
13. Tubulin photoaffinity labeling with biotin-tagged derivatives of potent diketopiperazine antimicrotubule agents.
Yamazaki Y; Kohno K; Yasui H; Kiso Y; Akamatsu M; Nicholson B; Deyanat-Yazdi G; Neuteboom S; Potts B; Lloyd GK; Hayashi Y
Chembiochem; 2008 Dec; 9(18):3074-81. PubMed ID: 19012291
[TBL] [Abstract][Full Text] [Related]
14. Tubulin-interactive natural products as anticancer agents.
Kingston DG
J Nat Prod; 2009 Mar; 72(3):507-15. PubMed ID: 19125622
[TBL] [Abstract][Full Text] [Related]
15. Intramolecular hydrogen bonding as a determinant of the inhibitory potency of N-unsubstituted imidazole derivatives towards mammalian hemoproteins.
Perrin L; André F; Aninat C; Ricoux R; Mahy JP; Shangguan N; Joullié MM; Delaforge M
Metallomics; 2009 Mar; 1(2):148-56. PubMed ID: 21305108
[TBL] [Abstract][Full Text] [Related]
16. Imidazole piperazines: SAR and development of a potent class of cyclin-dependent kinase inhibitors with a novel binding mode.
Finlay MR; Acton DG; Andrews DM; Barker AJ; Dennis M; Fisher E; Graham MA; Green CP; Heaton DW; Karoutchi G; Loddick SA; Morgentin R; Roberts A; Tucker JA; Weir HM
Bioorg Med Chem Lett; 2008 Aug; 18(15):4442-6. PubMed ID: 18617397
[TBL] [Abstract][Full Text] [Related]
17. Five- and six-membered ring opening of pyroglutamic diketopiperazine.
Parrish DA; Mathias LJ
J Org Chem; 2002 Mar; 67(6):1820-6. PubMed ID: 11895398
[TBL] [Abstract][Full Text] [Related]
18. Imidazoles as Potential Anticancer Agents: An Update on Recent Studies.
Sharma P; LaRosa C; Antwi J; Govindarajan R; Werbovetz KA
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299488
[TBL] [Abstract][Full Text] [Related]
19. Novel 3-substituted N-methylcarbazole-imidazolium salt derivatives: Synthesis and cytotoxic activity.
Li YH; Zhou B; Shi YM; Xun YP; Yang YH; Yang LJ
Chem Biol Drug Des; 2018 Jul; 92(1):1206-1213. PubMed ID: 29430875
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of benzo[d]imidazole derivatives as potential anti-cancer agents.
Alkahtani HM; Abbas AY; Wang S
Bioorg Med Chem Lett; 2012 Feb; 22(3):1317-21. PubMed ID: 22225635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
